Table 3 Sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio for HCC prediction using serum FGF21 in CHB patients.
Cut-off of Serum FGF21 (pg/ml) | Sensitivity (%) | Specificity (%) | Youden index | Positive likelihood ratio | Negative likelihood ratio |
|---|---|---|---|---|---|
200 | 100.0 | 74.8 | 1.748 | 3.968 | 0.000 |
225 | 77.8 | 76.5 | 1.543 | 3.311 | 0.290 |
250 | 66.7 | 80.9 | 1.476 | 3.492 | 0.412 |
275 | 55.6 | 82.6 | 1.382 | 3.195 | 0.538 |
300 | 55.6 | 84.3 | 1.399 | 3.541 | 0.527 |
325 | 55.6 | 86.1 | 1.417 | 4.000 | 0.516 |
350 | 55.6 | 89.6 | 1.452 | 5.346 | 0.496 |
375 | 55.6 | 93.0 | 1.486 | 7.943 | 0.477 |
400 | 44.4 | 93.0 | 1.374 | 6.343 | 0.598 |
